Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03543124
Other study ID # VA
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date May 21, 2018
Est. completion date December 31, 2023

Study information

Verified date July 2023
Source VA Greater Los Angeles Healthcare System
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Water exchange (WE) method has been shown to reduce medication requirement and pain experience during the colonoscopy. Cap-assisted colonoscopy aided by air may also reduced the insertion pain. Therefore, the immediate aim of this study is to assess the generalizability of the impact of WE plus cap (WECAC), as a potentially less painful insertion technique than WE. The control group will use water infusion in lieu of air insufflation during insertion of the colonoscope. The study group will added a cap onto the end of colonoscope during the WE method procedure. This study will also demonstrate if the WECAC method have a shorter insertion time and higher proximal colon adenoma detection rate (ADR) than WE alone in Veterans.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 256
Est. completion date December 31, 2023
Est. primary completion date September 30, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Informed/educated male and female Veterans undergoing screening, diagnostic or surveillance colonoscopy at participating sites, choosing scheduled unsedated colonoscopy for any reason Exclusion Criteria: - Decline to be randomized - Unable to give consent or respond to questionnaires - History of colon surgery, active inflammatory bowel disease, lower gastrointestinal bleeding - Therapeutic colonoscopy, proctosigmoidoscopy, bidirectional endoscopy - Inadequate consumption of bowel preparation - Known history of severe diverticulosis or diverticulitis - History of abdominal surgery previously requiring sedation for colonoscopy - Current narcotic/anxiolytic medication use - Prior unsuccessful experience with unsedation colonoscopy - Emergent colonoscopy - Evidence of colonic obstruction based on pre-colonoscopy clinical evaluation - Current participation in other studies - Medical condition that could increase the risk associated with colonoscopy - Medical condition that would preclude a benefit from colonoscopic screening - Prosthetic heart valve - Anticoagulant therapy - Nonmedical problems - Need for special precautions in performing colonoscopy - Request of on demand sedation

Study Design


Related Conditions & MeSH terms


Intervention

Device:
cap
A commercially available transparent cap (Olympus) will be fitted to the end of the colonoscope.
Other:
Water
Using water instead air to help insertion

Locations

Country Name City State
United States VA Palo Alto Healthcare System Livermore California
United States Sacramento VAMC, VA Northern California Healthcare System Mather California

Sponsors (3)

Lead Sponsor Collaborator
VA Greater Los Angeles Healthcare System VA Northern California Health Care System, VA Palo Alto Health Care System

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Real-time maximum insertion pain(RTMIP) score Pain during insertion reported to the unblinded assisting nursing, visual analogue scale (VAS): 0=no pain, 10=most severe pain. The highest pain score will be tabulated for analysis.Timing of data collection will be at the discretion of the nurse to minimize bias by colonoscopist behavior 2 hours
Secondary Proportion with no insertion pain Proportion report no pain during insertion time. 2 hours
Secondary Insertion time Time to cecum 2 hours
Secondary Proximal colon ADR ADR from cecum to splenic flexure 2 hours
See also
  Status Clinical Trial Phase
Completed NCT04101097 - Training and Validation of Models of Factors to Predict Inadequate Bowel Preparation Colonoscopy
Completed NCT03247595 - Testing How Well Magnesium Citrate Capsules Work as Preparation for a Colonoscopy N/A
Completed NCT04214301 - An Open-Label Preference Evaluation of BLI800 Phase 4
Withdrawn NCT05754255 - Comparison of High-flow Oxygen With or Without Nasal Positive Airway Pressure (PAP) During Propofol Sedation for Colonoscopy in an Ambulatory Surgical Center N/A
Recruiting NCT02484105 - Comforting Conversation During Colonoscopy: A Trial on Patient Satisfaction Phase 4
Active, not recruiting NCT02264249 - Residual Gastric Volume in Same Day Versus Split Dose and Evening Before Bowel Preparation N/A
Terminated NCT01978509 - The Affect of Low-Volume Bowel Preparation for Hospitalized Patients Colonoscopies N/A
Completed NCT01964417 - The Comparative Study Between Bowel Preparation Method Phase 3
Recruiting NCT01685970 - Comparison of Same-day 2 Sachets Picosulfate Versus High Volume PEG for Afternoon Colonoscopy Phase 3
Completed NCT01518790 - Short Course, Single-dose PEG 3350 for Colonoscopy Prep in Children N/A
Recruiting NCT00748293 - Achievement of Better Examinee Compliance on Colon Cleansing Using Commercialized Low-Residue Diet N/A
Completed NCT00779649 - MoviPrep® Versus HalfLytely®, Low-VolUme PEG Solutions for Colon Cleansing: An InvesTigator-blindEd, Randomized, Trial Phase 4
Completed NCT00671177 - Clinical Evaluation of Water Immersion Colonoscopy Insertion Technique N/A
Completed NCT00380497 - Pico-Salax Versus Poly-Ethylene Glycol for Bowel Cleanout Before Colonoscopy in Children Phase 4
Recruiting NCT00160823 - Impact of a Self-Administered Information Leaflet on Adequacy of Colonic Cleansing for in-Hospital Patients Phase 3
Completed NCT00390598 - PEG Solution (Laxabon®) 4L Versus Senna Glycoside (Pursennid® Ex-Lax) 36mg and PEG Solution (Laxabon®) 2L for Large Bowel Cleansing Prior to Colonoscopy Phase 2/Phase 3
Completed NCT00314418 - Patient Position and Impact on Colonoscopy Time N/A
Completed NCT00209573 - A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Elective Colonoscopy Phase 3
Completed NCT00427089 - Comparison of 2L NRL994 With NaP Preparation in Colon Cleansing Prior to Colonoscopies for Colon Tumor Screening Phase 3
Completed NCT05823350 - The Effect of Abdominal Massage on Pain and Distention After Colonoscopy N/A